9 May 2026
Designing the Next Generation of Antibiotics: Structure, SAR, and Strategy in Medicinal Chemistry (2000–2025)Publisher siteMedicinal Research Reviews, Synthesis of β-Lactam Compounds
UniversitiesSamia S. Hawas
Active, last published 2026
In synthesis and biological activity
Samia S.
Hawas
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Damietta University
Claim Your Profile5
H-index
84
Citations
Samia has not officially claimed their profile. If you are Samia, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
amia S. Hawas is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Samia's work has been cited 84 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×8Click Chemistry and Applications×5Cancer therapeutics and mechanisms×4Protein Degradation and Inhibitors×4Computational Drug Discovery Methods×2
04 · Where I am
Affiliations
Affiliation on published researchDamietta UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works5 May 2026
Advances in SIRT2‐Targeted Therapeutics: Structural Insights, Chemical Strategies, and Degrader TechnologiesPublisher siteMedicinal Research Reviews, Sirtuins and Resveratrol in Medicine
1 May 2026
Designing Telomerase Inhibitors for Cancer Therapy: Mechanistic Insights, Medicinal Chemistry Strategies, Challenges, and Future DirectionsPublisher siteArchiv der Pharmazie, Telomeres, Telomerase, and Senescence
16 Apr 2026
Receptor-interacting protein kinase 2 (RIPK2): Structural insights, pathophysiological roles, and medicinal chemistry advances in inhibitor designPublisher siteBioorganic Chemistry, Melanoma and MAPK Pathways
1 Apr 2026
Targeting the Menin– <i>KMT2A</i> Interface: Medicinal Chemistry Rules Governing Reversible, Covalent, and Degrader InhibitorsPublisher siteChemical Biology & Drug Design, Microtubule and mitosis dynamics
29 Mar 2026
PTC‐Assisted Chemoselective <i>S</i> ‐Alkylation of 5‐Mercapto‐1,3,4‐Oxadiazol Derivative: Multi‐Target Anticancer via EGFR, Telomerase, and Thymidylate Synthase Inhibition With Apoptosis InductionPublisher siteDrug Development Research, Synthesis and biological activity
27 Feb 2026
Fragment merging design, synthesis, and biological evaluation of novel methyl Selanyl– And thiazolidinedione-based hybrids as potent anticancer inducing apoptosis and cell cycle arrestPublisher siteBioorganic & Medicinal Chemistry, Synthesis and biological activity
1 Jan 2025Open access10cites
Medicinal chemistry perspectives on anticancer drug design based on clinical applications (2015–2025)Publisher siteRSC Advances, Advanced Breast Cancer Therapies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Samia?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you